Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The genetic basis of myelodysplasia and its clinical relevance
Mario Cazzola, Matteo Giovanni Della Porta, Luca Malcovati
Blood (2013) Vol. 122, Iss. 25, pp. 4021-4034
Open Access | Times Cited: 329

Showing 1-25 of 329 citing articles:

Leukemia-Associated Somatic Mutations Drive Distinct Patterns of Age-Related Clonal Hemopoiesis
Thomas McKerrell, Naomi Park, Thaidy Moreno-Rodriguez, et al.
Cell Reports (2015) Vol. 10, Iss. 8, pp. 1239-1245
Open Access | Times Cited: 485
Clinical significance of somatic mutation in unexplained blood cytopenia
Luca Malcovati, Anna Gallí, Erica Travaglino, et al.
Blood (2017) Vol. 129, Iss. 25, pp. 3371-3378
Open Access | Times Cited: 426
Molecular landscape of acute myeloid leukemia in younger adults and its clinical relevance
David Grimwade, Adam Ivey, Brian J.P. Huntly
Blood (2015) Vol. 127, Iss. 1, pp. 29-41
Open Access | Times Cited: 400
SF3B1 mutation identifies a distinct subset of myelodysplastic syndrome with ring sideroblasts
Luca Malcovati, Mohsen Karimi, Elli Papaemmanuil, et al.
Blood (2015) Vol. 126, Iss. 2, pp. 233-241
Open Access | Times Cited: 399
Myelodysplastic Syndromes
Mario Cazzola
New England Journal of Medicine (2020) Vol. 383, Iss. 14, pp. 1358-1374
Closed Access | Times Cited: 369
Clinical effect of driver mutations of JAK2, CALR, or MPL in primary myelofibrosis
Elisa Rumi, Daniela Pietra, Cristiana Pascutto, et al.
Blood (2014) Vol. 124, Iss. 7, pp. 1062-1069
Open Access | Times Cited: 366
Genetic abnormalities in myelodysplasia and secondary acute myeloid leukemia: impact on outcome of stem cell transplantation
Tetsuichi Yoshizato, Yasuhito Nannya, Yoshiko Atsuta, et al.
Blood (2017) Vol. 129, Iss. 17, pp. 2347-2358
Open Access | Times Cited: 312
Acute Myeloid Leukemia: A Concise Review
Jennifer N. Saultz, Ramiro Garzon
Journal of Clinical Medicine (2016) Vol. 5, Iss. 3, pp. 33-33
Open Access | Times Cited: 305
Genetics of MDS
Seishi Ogawa
Blood (2019) Vol. 133, Iss. 10, pp. 1049-1059
Open Access | Times Cited: 299
Transcriptional diversity during lineage commitment of human blood progenitors
Lu Chen, Myrto Kostadima, Joost H.A. Martens, et al.
Science (2014) Vol. 345, Iss. 6204
Open Access | Times Cited: 279
SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS
Luca Malcovati, Kristen E. Stevenson, Elli Papaemmanuil, et al.
Blood (2020) Vol. 136, Iss. 2, pp. 157-170
Open Access | Times Cited: 249
Driver somatic mutations identify distinct disease entities within myeloid neoplasms with myelodysplasia
Luca Malcovati, Elli Papaemmanuil, Ilaria Ambaglio, et al.
Blood (2014) Vol. 124, Iss. 9, pp. 1513-1521
Open Access | Times Cited: 235
Characteristic repartition of monocyte subsets as a diagnostic signature of chronic myelomonocytic leukemia
Dorothée Selimoglu‐Buet, Orianne Wagner‐Ballon, Véronique Saada, et al.
Blood (2015) Vol. 125, Iss. 23, pp. 3618-3626
Open Access | Times Cited: 231
Clinical Effects of Driver Somatic Mutations on the Outcomes of Patients With Myelodysplastic Syndromes Treated With Allogeneic Hematopoietic Stem-Cell Transplantation
Matteo Giovanni Della Porta, Anna Gallí, Andrea Bacigalupo, et al.
Journal of Clinical Oncology (2016) Vol. 34, Iss. 30, pp. 3627-3637
Open Access | Times Cited: 230
Diagnosis, risk stratification, and response evaluation in classical myeloproliferative neoplasms
Elisa Rumi, Mario Cazzola
Blood (2016) Vol. 129, Iss. 6, pp. 680-692
Open Access | Times Cited: 226
Impact of TP53 mutation variant allele frequency on phenotype and outcomes in myelodysplastic syndromes
David A. Sallman, Rami S. Komrokji, Christine Vaupel, et al.
Leukemia (2015) Vol. 30, Iss. 3, pp. 666-673
Open Access | Times Cited: 202
From Janus kinase 2 to calreticulin: the clinically relevant genomic landscape of myeloproliferative neoplasms
Mario Cazzola, Róbert Královics
Blood (2014) Vol. 123, Iss. 24, pp. 3714-3719
Open Access | Times Cited: 195
The impact of TP53 mutations and TP53 deletions on survival varies between AML, ALL, MDS and CLL: an analysis of 3307 cases
Anna Stengel, Wolfgang Kern, Torsten Haferlach, et al.
Leukemia (2016) Vol. 31, Iss. 3, pp. 705-711
Closed Access | Times Cited: 195
Clonal hematopoiesis in acquired aplastic anemia
Seishi Ogawa
Blood (2016) Vol. 128, Iss. 3, pp. 337-347
Open Access | Times Cited: 180
Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features in Myelodysplastic Syndromes
Matteo Bersanelli, Erica Travaglino, Manja Meggendorfer, et al.
Journal of Clinical Oncology (2021) Vol. 39, Iss. 11, pp. 1223-1233
Open Access | Times Cited: 172
Aberrant splicing and defective mRNA production induced by somatic spliceosome mutations in myelodysplasia
Yusuke Shiozawa, Luca Malcovati, Anna Gallí, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 165
Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic Syndromes
Elisabetta Sauta, Marie Robin, Matteo Bersanelli, et al.
Journal of Clinical Oncology (2023) Vol. 41, Iss. 15, pp. 2827-2842
Open Access | Times Cited: 66
Imetelstat in patients with lower-risk myelodysplastic syndromes who have relapsed or are refractory to erythropoiesis-stimulating agents (IMerge): a multinational, randomised, double-blind, placebo-controlled, phase 3 trial
Uwe Platzbecker, Valeria Santini, Pierre Fenaux, et al.
The Lancet (2023) Vol. 403, Iss. 10423, pp. 249-260
Closed Access | Times Cited: 55
Predictive factors for the outcome of allogeneic transplantation in patients with MDS stratified according to the revised IPSS-R
Matteo Giovanni Della Porta, Emilio Paolo Alessandrino, Andrea Bacigalupo, et al.
Blood (2014) Vol. 123, Iss. 15, pp. 2333-2342
Open Access | Times Cited: 171
Mechanisms for U2AF to define 3′ splice sites and regulate alternative splicing in the human genome
Changwei Shao, Bo Yang, Tongbin Wu, et al.
Nature Structural & Molecular Biology (2014) Vol. 21, Iss. 11, pp. 997-1005
Open Access | Times Cited: 169
Page 1 - Next Page

Scroll to top